Nuvation Bio Inc. NUVB
$5.21
▲ +3.36% 24H
About
Nuvation Bio Inc. is a biopharmaceutical company focused on developing innovative therapies for oncology patients. Its primary purpose is to research and advance novel drug candidates targeting various forms of cancer, particularly those for which few treatments currently exist. The company's pipeline is centered on ne…
SectorHealthcare
ExchangeNYSE
IndustryBiotechnology
CountryUnited States
Employees307
TickerNUVB
Statistics
Market Cap$1.81B
Revenue (TTM)$62.9M
Net Income-$204.6M
Net Margin-325.3%
EPS$-0.60
P/E-8.36
P/S12.00
P/B5.36
EV/EBITDA-9.45
ROE-39.5%
Dividend Yield—
Price$5.21
Data: Twelve Data · Revenue = mcap / P/S